BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22607487)

  • 1. Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up.
    Polasek R; Kucera P; Nedbal P; Roubicek T; Belza T; Hanuliakova J; Horak D; Wichterle D; Kautzner J
    BMC Cardiovasc Disord; 2012 May; 12():34. PubMed ID: 22607487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of measures of ventricular delay on cardiac resynchronization therapy response.
    Field ME; Yu N; Wold N; Gold MR
    Heart Rhythm; 2020 Apr; 17(4):615-620. PubMed ID: 31765805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density epicardial activation mapping to optimize the site for video-thoracoscopic left ventricular lead implant.
    Polasek R; Skalsky I; Wichterle D; Martinca T; Hanuliakova J; Roubicek T; Bahnik J; Jansova H; Pirk J; Kautzner J
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):882-888. PubMed ID: 24724625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
    PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Ventricular Lead Electrical Delay Is a Predictor of Mortality in Patients With Cardiac Resynchronization Therapy.
    Roubicek T; Wichterle D; Kucera P; Nedbal P; Kupec J; Sedlakova J; Cerny J; Stros J; Kautzner J; Polasek R
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1113-21. PubMed ID: 26338831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block.
    Engels EB; Végh EM; Van Deursen CJ; Vernooy K; Singh JP; Prinzen FW
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):176-83. PubMed ID: 25230363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.
    Sommer A; Kronborg MB; Nørgaard BL; Stephansen C; Poulsen SH; Kristensen J; Gerdes C; Nielsen JC
    Europace; 2018 Oct; 20(10):1630-1637. PubMed ID: 29377984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response.
    Bogaard MD; Hesselink T; Meine M; Loh P; Hauer RN; Cramer MJ; Doevendans PA; Tuinenburg AE
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1237-45. PubMed ID: 22734629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programming Cardiac Resynchronization Therapy for Electrical Synchrony: Reaching Beyond Left Bundle Branch Block and Left Ventricular Activation Delay.
    Varma N; O'Donnell D; Bassiouny M; Ritter P; Pappone C; Mangual J; Cantillon D; Badie N; Thibault B; Wisnoskey B
    J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29432133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
    van Everdingen WM; Zweerink A; Cramer MJ; Doevendans PA; Nguyên UC; van Rossum AC; Prinzen FW; Vernooy K; Allaart CP; Meine M
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005912. PubMed ID: 29874169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrioventricular optimization in cardiac resynchronization therapy with quadripolar leads: should we optimize every pacing configuration including multi-point pacing?
    van Everdingen WM; Zweerink A; Salden OAE; Cramer MJ; Doevendans PA; van Rossum AC; Prinzen FW; Vernooy K; Allaart CP; Meine M
    Europace; 2019 Jan; 21(1):e11-e19. PubMed ID: 30052906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Interventricular Electrical Delay on Atrioventricular Optimization for Cardiac Resynchronization Therapy.
    Gold MR; Yu Y; Singh JP; Birgersdotter-Green U; Stein KM; Wold N; Meyer TE; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006055. PubMed ID: 30354310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
    Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
    BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved patient selection for cardiac resynchronization therapy by normalization of QRS duration to left ventricular dimension.
    Zweerink A; Wu L; de Roest GJ; Nijveldt R; de Cock CC; van Rossum AC; Allaart CP
    Europace; 2017 Sep; 19(9):1508-1513. PubMed ID: 27707784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring device settings in cardiac resynchronization therapy using electrograms from pacing electrodes.
    Engels EB; Mafi-Rad M; Hermans BJM; Aranda A; van Stipdonk AMW; Rienstra M; Scheerder COS; Maass AH; Prinzen FW; Vernooy K
    Europace; 2018 Jul; 20(7):1146-1153. PubMed ID: 29106563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.